[artículo] 
inPsychiatric Clinics of North America > Año 1998- Vol. 21 No. 1 (Marzo) . - pp. 181-202

Título :	Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia
Tipo de documento:	texto impreso
Autores:	Julie Magno Zito, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 181-202
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Benzodiazepinas, Ensayos clínicos, Clozapina, Pirenzepina, Risperidona, Esquizofrenia.
Resumen:	Inevitably, the greater availability of more costly antipsychotic medications has resulted in attempts to regulate the use of these agents. Early objections over the cost of treatment with clozapine or risperidone have in part been mollified by preliminary statistics on the cost effectiveness of these agents.
Link:	./index.php?lvl=notice_display&id=25074

[artículo] Pharmacoeconomics of the new antipsychotics for the treatment of schizophrenia [texto impreso] / Julie Magno Zito, Autor . - 2020 . - pp. 181-202.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 1998- Vol. 21 No. 1 (Marzo) . - pp. 181-202

Palabras clave:	Benzodiazepinas, Ensayos clínicos, Clozapina, Pirenzepina, Risperidona, Esquizofrenia.
Resumen:	Inevitably, the greater availability of more costly antipsychotic medications has resulted in attempts to regulate the use of these agents. Early objections over the cost of treatment with clozapine or risperidone have in part been mollified by preliminary statistics on the cost effectiveness of these agents.
Link:	./index.php?lvl=notice_display&id=25074